Affordable Access

Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study.

Authors
  • Bergeron, C
  • Dubourg, L
  • Chastagner, P
  • Mechinaud, F
  • Plouvier, E
  • Desfachelles, A S
  • Dusol, F
  • Pautard, B
  • Edan, C
  • Plantaz, D
  • Froehlich, P
  • Rubie, H
Type
Published Article
Journal
Pediatric blood & cancer
Publication Date
Jul 01, 2005
Volume
45
Issue
1
Pages
32–36
Identifiers
PMID: 15768383
Source
Medline
License
Unknown

Abstract

With a 6-year follow-up the combination of VP16 and carboplatin given at conventional doses is safe on renal and hearing functions in infants with unresectable neuroblastomas treated according to SFOP NB90.

Report this publication

Statistics

Seen <100 times